Mario Meza-Segura
Mario Meza-Segura has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Abigail L. Zeamer
UMass Chan Medical School
1 shared publication - Ana Maldonado-Contreras
Affiliation Department of Microbiology, Program of Microbiome Dynamics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America
1 shared publication - Ann M. Moormann
Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA, USA
1 shared publication Beth A. McCormick
Department of Microbiology and Physiological Systems
1 shared publication- Beth A. McCormick
Department of Microbiology, UMass Chan Medical School, Worcester, MA 01655, USA
1 shared publication - Christian Mueller
Genomic Medicine Unit, Sanofi, Waltham, Massachusetts, USA
1 shared publication
Latest Publications
- Open Access
- 31 March 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 155 (4)
Enterotoxigenic and enteroaggregative Escherichia coli: prevalence, pathogenesis and murine models
- 31 March 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 155 (4)
Open AccessEnterotoxigenic and enteroaggregative Escherichia coli: prevalence, pathogenesis and murine models
- Open Access
- 21 December 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (6) , e0283321
SepA EnhancesShigellaInvasion of Epithelial Cells by Degrading Alpha-1 Antitrypsin and Producing a Neutrophil Chemoattractant
Shigellais the second leading cause of diarrheal death globally. In this study, we identified the host protein targets of SepA,Shigella’s major protein secreted in culture.
- 21 December 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (6) , e0283321
Open AccessSepA EnhancesShigellaInvasion of Epithelial Cells by Degrading Alpha-1 Antitrypsin and Producing a Neutrophil Chemoattractant
Shigellais the second leading cause of diarrheal death globally. In this study, we identified the host protein targets of SepA,Shigella’s major protein secreted in culture.
- Open Access
- 22 October 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (20)
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID
In the COVID-19 pandemic, caused by SARS-CoV-2, many individuals experience prolonged symptoms, termed long-lasting COVID-19 symptoms (long COVID). Long COVID is thought to be linked to immune dysregulation due to harmful inflammation, with the exact causes being unknown. Given the role of the microbiome in mediating inflammation, we aimed to examine the relationship between the oral microbiome and the duration of long COVID symptoms. Tongue swabs were collected from patients presenting with COVID-19 symptoms. Confirmed infections were followed until resolution of all symptoms. Bacterial composition was determined by metagenomic sequencing. We used random forest modeling to identify microbiota and clinical covariates that are associated with long COVID symptoms. Of the patients followed, 63% developed ongoing symptomatic COVID-19 and 37% went on to long COVID. Patients with prolonged symptoms had significantly higher abundances of microbiota that induced inflammation, such as members of the genera Prevotella and Veillonella , which, of note, are species that produce LPS. The oral microbiome of patients with long COVID was similar to that of patients with chronic fatigue syndrome. Altogether, our findings suggest an association with the oral microbiome and long COVID, revealing the possibility that dysfunction of the oral microbiome may have contributed to this draining disease.
- 22 October 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (20)
Open AccessInflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID
In the COVID-19 pandemic, caused by SARS-CoV-2, many individuals experience prolonged symptoms, termed long-lasting COVID-19 symptoms (long COVID). Long COVID is thought to be linked to immune dysregulation due to harmful inflammation, with the exact causes being unknown. Given the role of the microbiome in mediating inflammation, we aimed to examine the relationship between the oral microbiome and the duration of long COVID symptoms. Tongue swabs were collected from patients presenting with COVID-19 symptoms. Confirmed infections were followed until resolution of all symptoms. Bacterial composition was determined by metagenomic sequencing. We used random forest modeling to identify microbiota and clinical covariates that are associated with long COVID symptoms. Of the patients followed, 63% developed ongoing symptomatic COVID-19 and 37% went on to long COVID. Patients with prolonged symptoms had significantly higher abundances of microbiota that induced inflammation, such as members of the genera Prevotella and Veillonella , which, of note, are species that produce LPS. The oral microbiome of patients with long COVID was similar to that of patients with chronic fatigue syndrome. Altogether, our findings suggest an association with the oral microbiome and long COVID, revealing the possibility that dysfunction of the oral microbiome may have contributed to this draining disease.